Clopidogrel and the main circulating inactive metabolite bind reversibly in vitro to human plasma proteins (98% and 94%, respectively).
I-Clopidogrel kanye ne-metabolite yayo enkulu engasebenzi ejikeleza ngeplasma ibopha ngokunamathela kumaprotheni e-plasma womuntu ngaphansi kwezimo in vitro (98% no-94%, ngokulandelana).